1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Acute Brain Injuries in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kompanje, EJ; Maas, AI; Murray, GD; Ohman, J; Slieker, FJ; Stocchetti, N; Teasdale, SG | 1 |
| Nimmo, AJ; Vink, R | 1 |
| Butcher, I; Lecky, FE; Lingsma, HF; Lu, J; Maas, AI; McHugh, GS; Murray, GD; Perel, P; Roozenbeek, B; Steyerberg, EW; Weir, J | 1 |
| Van Den Heuvel, C; Vink, R | 1 |
| Guha, A | 1 |
| Henney, H; Kassem, N; Knoller, N; Legrand, V; Maas, AI; Mangelus, M; Muizelaar, JP; Murray, G; Stocchetti, N | 1 |
| Biegon, A; Joseph, AB | 1 |
| Belkin, M; Schwartz, M; Yoles, E | 1 |
| Bass, R; Ben-Hur, T; Gallily, R; Mechoulam, R; Shohami, E | 1 |
| Mechoulam, R; Panikashvili, D; Shohami, E | 1 |
| Bedell, EA; Prough, DS | 1 |
5 review(s) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Acute Brain Injuries
| Article | Year |
|---|---|
Multifunctional drugs for head injury.
Topics: Animals; Brain Edema; Brain Injuries; Cyclosporine; Dronabinol; Erythropoietin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinins; Magnesium; Minocycline; Mitochondria; Neuroprotective Agents; Oxidative Stress; Progesterone; Psychotropic Drugs; Thyrotropin-Releasing Hormone; Toll-Like Receptors | 2009 |
Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury.
Topics: Animals; Brain Injuries; Cyclosporine; Dexamethasone; Dronabinol; Humans; Magnesium; Mitochondria; Neuroprotective Agents; Oxidative Stress; Progesterone | 2004 |
Management of traumatic brain injury: some current evidence and applications.
Topics: Absorptiometry, Photon; Anti-Inflammatory Agents; Barbiturates; Brain Injuries; Clinical Trials as Topic; Diuretics, Osmotic; Dronabinol; Humans; Hydrostatic Pressure; Hypothermia; Mannitol; Neuromuscular Blockade; Neuroprotective Agents; Osmotic Pressure; Sodium Chloride | 2004 |
Development of HU-211 as a neuroprotectant for ischemic brain damage.
Topics: Animals; Brain Injuries; Brain Ischemia; Dronabinol; Excitatory Amino Acid Antagonists; Gerbillinae; Head Injuries, Closed; Neuroprotective Agents; Rats; Receptors, N-Methyl-D-Aspartate | 1995 |
Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.
Topics: Animals; Brain; Brain Injuries; Cytokines; Dronabinol; Excitatory Amino Acid Antagonists; Head Injuries, Closed; Neuroprotective Agents; Tumor Necrosis Factor-alpha | 1997 |
2 trial(s) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Acute Brain Injuries
| Article | Year |
|---|---|
Importance of screening logs in clinical trials for severe traumatic brain injury.
Topics: Adolescent; Adult; Aged; Brain Injuries; Dronabinol; Feasibility Studies; Forms and Records Control; Humans; Medical Records; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care; Patient Selection; Piperazines | 2008 |
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
Topics: Adolescent; Adult; Aged; Brain Injuries; Chi-Square Distribution; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Follow-Up Studies; Glasgow Coma Scale; Humans; Intracranial Pressure; Male; Middle Aged; Neuroprotective Agents; Odds Ratio; Quality of Life; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
4 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Acute Brain Injuries
| Article | Year |
|---|---|
Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic mod
Topics: Apolipoproteins E; Brain Injuries; Dronabinol; Glasgow Outcome Scale; Guanidines; Humans; Hypothermia, Induced; Logistic Models; Models, Statistical; Neuroprotective Agents; Prognosis; Registries; ROC Curve | 2012 |
HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy.
Topics: Action Potentials; Animals; Axons; Brain Injuries; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Electrophysiology; Energy Metabolism; Evoked Potentials, Visual; Male; NAD; Nerve Crush; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Time Factors | 1996 |
Cannabinoids and brain injury: therapeutic implications.
Topics: Animals; Arachidonic Acids; Brain; Brain Injuries; Cannabinoid Receptor Modulators; Cannabinoids; Clinical Trials, Phase III as Topic; Dronabinol; Endocannabinoids; Glycerides; Humans; Neuroprotective Agents; Pain; Polyunsaturated Alkamides; Rats | 2002 |
Dexanabinol as a treatment for traumatic brain injury: will another therapeutic promise be broken?
Topics: Brain Injuries; Clinical Trials, Phase II as Topic; Dronabinol; Humans; Neuroprotective Agents | 2002 |